RemeGen Co., Ltd. ( 9995.HK) - Stock Earnings
9995.HK Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q3 | -303.5 million HKD | 467.1 million HKD |
| 2024Q4 | -352.7 million HKD | 501.3 million HKD |
| 2025Q3 | — HKD | 621.9 million HKD |
9995.HK Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -1.5 billion HKD | 1.1 billion HKD |
| 2024 | -1.4 billion HKD | 1.7 billion HKD |
| 2025 | 67.7 million HKD | 3.2 billion HKD |
| 2026 Est. | — | — |
9995.HK
Price: HK$73.35
52 week price:
Earnings Per Share: -2.40 HKD
P/E Ratio: -35.54
Exchange: HKG
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 46.9 billion